These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4396705)

  • 21. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
    Caputi AP; Marmo E; Saini RK
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
    Maruyama Y; Awaji T; Inoue M; Takeo S
    Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observations on the sub-division of beta-adrenoreceptors in the circulation of the dog.
    Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1970 May; 39(1):184P-185P. PubMed ID: 4392961
    [No Abstract]   [Full Text] [Related]  

  • 25. Further studies on the pressor action of propranolol in the rat.
    Yamamoto J; Sekiya A
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):347-54. PubMed ID: 4403390
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance to beta-adrenoceptor stimulants and death from bronchial asthma.
    Blackwell EW; Conolly ME; Davies DS; Dollery CT; George CF
    Br J Pharmacol; 1971 Feb; 41(2):410P. PubMed ID: 4396706
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetics of M&B 17,803A in animals and man.
    Basil B; Collins RF; Cuthbert MF
    Br J Pharmacol; 1973 Mar; 47(3):620P. PubMed ID: 4147192
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of pindolol on the metabolic activities of adrenaline].
    Schmitt H; Lucet B
    C R Seances Soc Biol Fil; 1970; 164(11):2193-5. PubMed ID: 4399994
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of beta-adrenergic blockade on exercise metabolism in dogs.
    Brzezinska Z; Nazar K
    Arch Int Physiol Biochim; 1970 Dec; 78(5):883-92. PubMed ID: 4101921
    [No Abstract]   [Full Text] [Related]  

  • 30. Interactions between sympathomimetic agonists and blocking agents: cardiac effects of phenylephrine and isoproterenol.
    Márquez MT; Mikulić LE; Aramendía P
    Methods Find Exp Clin Pharmacol; 1981; 3(5):283-9. PubMed ID: 7329156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of the coronary vascular responses to catecholamines, using a modified Langendorff heart preparation.
    Broadley KJ
    Br J Pharmacol; 1970 Dec; 40(4):617-29. PubMed ID: 4395502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nicotine and propranolol].
    Malmejac J; Schlotterer M; Wassermann D
    J Physiol (Paris); 1971; 63(2):74A. PubMed ID: 4397833
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of alpha and beta blocker properties of parahydroxybenzonitrile on the cardiovascular system of rats].
    Cheav SL; Kirkiacharian S; Piéri F; Poisson D
    Ann Pharm Fr; 1998; 56(5):205-8. PubMed ID: 9805819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of acebutolol, an adrenergic beta receptor blocker, on plasma free fatty acids fluctuations caused by isoproterenol administration].
    Nishihara K; Suzuki Y; Kobayashi A; Abe N; Kanagawa T
    Kokyu To Junkan; 1983 Nov; 31(11):1167-71. PubMed ID: 6145198
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
    Madan BR; Gupta RS; Jain BK
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer.
    Williams EM; Bagwell EE; Singh BN
    Cardiovasc Res; 1973 Mar; 7(2):226-40. PubMed ID: 4144352
    [No Abstract]   [Full Text] [Related]  

  • 37. Maintenance of tonic vasomotor activity by alpha and beta adrenergic mechanisms in medullary cardiovascular centers.
    Ito A; Schanberg SM
    J Pharmacol Exp Ther; 1974 May; 189(2):392-404. PubMed ID: 4829221
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective beta adrenergic receptor antagonism in the anesthetized dog.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1974 Feb; 188(2):357-67. PubMed ID: 4149462
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICI 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias.
    Hashimoto K; Nakayama K; Oshima T; Kumakura S
    Experientia; 1971 Jun; 27(6):666-7. PubMed ID: 4397569
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of fasting and hypophysectomy on the lipolytic and hyperglycemic action of adrenaline in dogs treated with beta blockaders].
    Berlan M; Baïsset MA; Agid MR
    C R Seances Soc Biol Fil; 1974; 168(1):117-23. PubMed ID: 4154802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.